PEDF: A multifaceted neurotrophic factor

Nature Reviews Neuroscience

Volumn 4, Issue 8, 2003, Pages 628-636

  Tombran Tink, Joyce ^a   Barnstable, Colin J ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; PROTEIN; SERINE PROTEINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFORMATION; CRYSTAL STRUCTURE; DRUG EFFICACY; DRUG MECHANISM; GENE TRANSFER; GENETIC TRANSFECTION; NEOVASCULARIZATION (PATHOLOGY); NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RETINA DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; STROKE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BRAIN; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; VITREOUS BODY;

ANIMALS; BRAIN; EYE PROTEINS; HUMANS; NERVE GROWTH FACTORS; PROTEINS; SERPINS; VITREOUS BODY;

EID: 0042737443     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn1176     Document Type: Article

References (91)

1. Tombran-Tink, J. & Johnson, L. V Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci. 30, 1700-1707 (1989).
2. Tombran-Tink, J., Chader, G. G. & Johnson, L. V. PEDF: a pigment epithelium derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53, 411-414 (1991).
3. Tombran-Tink, J., Shivaram, S. M., Chader, G. J., Johnson, L. V. & Bok, D. Expression, secretion, and age- related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J. Neurosci. 15, 4992-5003 (1995).
4. Perez-Mediavilla, L. A. et al. Sequence and expression analysis of bovine pigment epithelium-derived factor. Biochim. Biophys. Acta. 1398, 203-214 (1998).
5. Wu, Y. Q., Notario, V., Chader, G. J. & Becerra, S. P. Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. Protein Expr. Purif. 6, 447-456 (1995).
6. Karakousis, P C. et al. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mot. Vis. 7, 153-163 (2001).
7. Ogata, N. et al. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1168-1175 (2002).
8. Behling, K. C., Surace, E. M. & Bennett, J. Pigment epithelium-derived factor expression in the developing mouse eye. Mol. Vis. 8, 449-454 (2002).
9. Zhang, S. S-M., Fu, X. Y. & Barnstable, C. J. Molecular mechanisms of vertebrate retinal development. Mol. Neurobiot. 26, 137-152 (2002).
10. Barnstable, C. J. Molecular aspects of development of mammalian optic cup and formation of retinal cell types. Prog. Retin. Eye Res. 10, 69-88 (1991).
11. Ortego, J., Escribano, J., Becerra, S. P. & Coca-Prados, M. Gene expression of the neurotrophic pigment epithelium- derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor. Invest. Ophthalmol. Vis. Sci. 37, 2759-2767 (1996).
12. Tombran-Tink, J. In Degenerative Diseases of the Retina (eds Anderson, R. E., Lavail, M. & Hollyfield J.) 51-60 (Plenum Press, New York, 1995).
13. Wu, Y. Q. & Becerra, S. P Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing. Invest. Ophthalmol. Vs. Sci. 37, 1984-1993 (1996).
14. Spranger, J. et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 50, 2641-2645 (2001).
15. Simonovic, M., Gettins, P G. W. & Volz, K., Crystal structure of human PEDF, a potent antiangiogenic and neurite growth-promoting factor. Proc. Natl Acad. Sci. USA 98, 11131-11135 (2001).
16. Kozaki, K. et al. Isolation, purification and characterization of a collagen-associated serpin, Caspin, produced by murine colon adenocarcinoma cells. J. Biol. Chem. 273, 15125-15130 (1998).
17. Meyer, C., Notari, L. & Becerra, S. P. Mapping the type I collagen-binding site on pigment epithelium-derived factor. J. Biol. Chem. 277, 45400-45407 (2002).
18. Alberdi, E., Hyde, C. C. & Becerra, S. P. Pigment epithelium- derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry 37, 10643-10652 (1998).
19. Bilak, M. M. et al. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J. Neuropathol. Exp. Neurol. 58, 719-728 (1999).
20. Tombran-Tink, J. et al. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vis. 2, 11 (1996).
21. Sariola, H. The neurotrophic factors in non-neuronal tissues. Cell. Mol. Life Sci. 58, 1061-1066 (2001).
22. Tombran-Tink, J., Pawar, H., Swaroop, A., Rodriguez, I. & Chader, G. J., Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics 19, 266-272 (1994).
23. Goliath, R. et al. Fine localization of the gene for autosomal dominant Retinitis pigmentosa on chromosome 17p. Am. J. Hum. Genet. 57, 962-965 (1995).
24. Koenekoop, R. et al. Four polymorphic variations in the PEDF gene identified during the mutation screening of patients with Leber congenital amaurosis. Mol. Vis. 5, 10 (1999).
25. Steele, F. R., Chader, G. J., Johnson, L. V. & Tombran-Tink, J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl Acad. Sci. USA 90, 1526-1530 (1993).
26. Bilak, M. M. et al. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J. Neurosci. 22, 9378-9386 (2002).
27. Becerra, S. P., Sagasti, A., Spinella, P. & Notario, V. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J. Biol. Chem. 270, 25992-25999 (1995).
28. Alberdi, E., Aymerich, M. S. & Becerra, S. P. Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor. J. Biol. Chem. 274, 31605-31612 (1999).
29. Aymerich, M. S., Alberdi, E. M., Martinez, A. & Becerra, S. P. Evidence for pigment epithelium-derived factor receptors in the neural retina. Invest. Ophthalmol. Vis. Sci. 42, 3287-3293 (2001).
30. Yabe, T, Wilson, D. & Schwartz, J. P NF-kB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J. Biol. Chem. 276, 43313-43319 (2001).
31. Volpert, O. V. et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor. Nature Med. 8, 349-357 (2002).
32. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. & Tschopp, J. NF-kB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21, 5299-5305 (2001).
33. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-kB and Erk signaling pathways. Curr. Biol. 10, 640-648 (2000).
34. 2+ accumulation. Proc. Natl Acad. Sci. USA 92, 9328-9332 (1995).
35. Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B. & Kaltschmidt, C. Inhibition of NF-kB potentiates amyloid p- mediated neuronal apoptosis. Proc. Natl Acad. Sci. USA 96, 9409-9414 (1999).
36. Mattson, M. P., Goodman, Y., Luo, H., Fu, W. & Furukawa, K. Activation of NF-kB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-97 (1997).
37. Glazner, G. W., Camandola, S. & Mattson, M. P. Nuclear factor-KB mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9. J. Neurochem. 75, 101 -108 (2000).
38. Lezoualc'h, F., Sagara, Y., Holsboe, F. & Behl, C. High constitutive NF-kB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18, 3224-3232 (1998).
39. Lin, B. et al. NF-kB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 6, 570-582 (1999).
40. Haiwood, F. G. et al. Regulation of FasL by NF-kB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells. J. Biol. Chem. 275, 10023-10029 (2000).
41. Grilli, M., Pizzi, M., Memo, M. & Spano, P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation. Science 274, 1383-1385 (1996).
42. Post, A., Crochemore, C., Uh, M., Holsboer, F. & Behl, C. Differential induction of NF-kB activity and neural cell death by antidepressants in vitro. Eur. J. Neurosci. 12, 4331-4337 (2000).
43. Post, A., Holsboer, F. & Behl, C. Induction of NF-kB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kB and neuroprotection by antioxidants. J. Neurosci. 18, 8236-8246 (1998).
44. Matsui, K., Fine, A., Zhu, B., Marshak-Rothstein, A. & Ju, S. T. Identification of two NF-kB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161, 3469-3473 (1998).
45. Hsu, S. C. et al. NF-KB-dependent Fas ligand expression. Eur. J. Immunol. 29, 2948-2956 (1999).
46. Chan, H., Bartos, D. P. & Owen-Schaub, L. B. Activation- dependent transcriptional regulation of the human Fas promoter requires NF-kB p50-p65 recruitment. Mol. Cell. Biol. 19, 2098-2108 (1999).
47. Kasibhatla, S., Genestier, L. & Green, D. R. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kB. J. Biol. Chem. 274, 987-992 (1999).
48. Li-Weber, M., Laur, O., Dern, K. & Krammer, P. H. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kB. Eur. J. Immunol. 30, 661 -670 (2000).
49. Taniwaki, T, Becerra, S. P., Chader, G. J. & Schwartz, J. P. Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J. Neurochem. 64, 2509-2517 (1995).
50. Houenou, L. J. et al. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol. 412, 506-514 (1999).
51. Araki, T. et al. Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J. Neurosci. Res. 53, 7-15 (1998).
52. Otori, Y., Wei, J. Y. & Barnstable, C. J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 39, 972-981 (1998).
53. DeCoster, M. A., Schabelman, E., Tombran-Tink, J. & Bazan, N. G. Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons. J. Neurosci. Res. 56, 604-610 (1999).
54. Cao, W. et al. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 42, 1646-1652 (2001).
55. LaVail, M. M. et al. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl Acad. Sci. USA 89, 11249-11253 (1992).
56. Stiemke, M. M., Landers, R. A., Al-Ubaidi, M. R. & Hollyfield, J. G. Photoreceptor outer segment development in Xenopus laevis: influence of the pigment epithelium. Dev. Biol. 162, 169-180 (1994).
57. Jablonski, M. M., Tombran-Tink, J., Mrazek, D. A. & Iannaccone, A. Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal. J. Neurosci. 20, 7149-7157 (2000).
58. Cayouette, M., Smith, S. B., Becerra, S. P. & Gravel, C. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol. Dis. 6, 523-532 (1999).
59. Cao, W. et al. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J. Neurosci. Res. 57, 789-800 (1999).
60. Ogata, N. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr. Eye Res. 22, 245-252 (2001).
61. Jablonski, M. M., Tombran-Tink, J. Mrazek, D. A. & Iannaccone A. Pigment epithelium-derived factor supports normal Muller cell development and glutamine synthetase expression after removal of the retinal pigment epithelium. Glia 35, 14-25 (2001).
62. Sugita, Y., Becerra, S. P., Chader, G. J. & Schwartz, J. P. Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J. Neurosci. Res. 49, 710-718 (1997).
63. Malchiodi-Albedi, F. et al. PEDF (Pigment epithelium-derived factor) promotes increase and maturation of pigment granules in pigment epithelial cells in neonatal albino rat retinal cultures. Int. J. Dev. Neurosci. 16, 423-432 (1998).
64. Dawson, D. W. et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science285, 245-248 (1999).
65. Ogata, N. et al. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am. J. Ophthalmol. 132, 378-382 (2001).
66. Holekamp, N. M., Bouck, N. & Volper, O. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am. J. Ophthalmol. 134, 220-227 (2002).
67. Ogata, N., Nishikawa, M., Nishimura, T, Mitsuma Y. & Matsumura, M. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Am. J. Ophthalmol. 133, 851-852 (2002).
68. Ohno-Matsui, K. et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J. Cell. Physiol. 189, 323-333 (2001).
69. Ogata, N., Nishikawa, M., Nishimura, T, Mitsuma, Y. & Matsumura M., Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am. J. Ophthalmol. 134, 348-353 (2002).
70. Gao, G. et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 489, 270-276 (2001).
71. Ogata, N., Tombran-Tink, J., Jo, N., Mrazek, D. & Matsumura, M. Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am. J. Ophthalmol. 132, 427-429 (2001).
72. Kuncl, R. W. et al. Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J. Neurochem. 81, 178-184 (2002).
73. Crawford, S. E. et al. Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J. Cell Sci. 114, 4421-4428 (2001).
74. Li, S., Chen, Y. & Wei, H. Muscle pigment epithelium-derived factor gene associating with tumorigenesis of B16 melanoma. Chin. J. Pathol. 30, 281-284 (2001).
75. Hjelmeland, L. M., Cristofalo, V J., Funk, W., Rakoczy, E. & Katz, M. L. Senescence of the retinal pigment epithelium. Mot. Vis. 5, 33 (1999).
76. DiPaolo, B. R., Pignolo, R. J. & Cristofalo, V. J. Identification of proteins differentially expressed in quiescent and proliferative^ senescent fibroblast cultures. Exp. Cell Res. 220, 178-185 (1995).
77. Coljee, V. W. et al. Regulation of EPC-1/PEDF in normal human fibroblasts is posttranscriptional. J. Cell. Biochem. 79, 442-452 (2000).
78. Lanza, R. P. et al. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 288, 665-669 (2000).
79. Rocchi, P., Ferreri, A. M., Simone, G., Bagnara, G. P & Paolucci G. Neuronal cell differentiation of human neuroblastoma cells by inducing agents in combination. Anticancer Res. 11, 1885-1889 (1991).
80. Adachi, Y. et al. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging. Cancer Res. 61, 7882-7888 (2001).
81. Ma, H. I. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral vector. Gene Ther. 9, 2-11 (2002).
82. Kirsch, K. M. Schackert, G. & Black, P M. Anti-angiogenic treatment strategies for malignant brain tumors. J. Neurooncol. 50, 149-163 (2000).
83. Griscelli, F. et al. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc. Natl Acad. Sci. USA 97, 6698-6703 (2000).
84. Mori, K. et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1994-2000 (2002).
85. Raisler, B. J., Berns, K. I., Grant, M. B., Beliaev, D. & Hauswirth, W. W. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proc. Natl Acad. Sci. USA 99, 8909-8914 (2002).
86. Semkova, I. et al. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc. Natl Acad. Sci. USA 99, 13090-13095 (2002).
87. Ino, H. & Chiba, T. Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo. J. Neurosci. 21, 6086-6094 (2001).
88. Raina, A. K. et al. Neurons in Alzheimer disease emerge from senescence. Mech. Ageing Dev. 123, 3-9 (2001).
89. Konishi, Y, Lehtinen, M., Donovan, N. & Bonni, A. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol. Cell 9, 1005-1016 (2002).
90. Nguyen, M. D., Mushynski, W. E. & Julien, J. P. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ. 9, 1294-1306 (2002).
91. Doll, J. A. et al. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nature Med. 9, 774-780 (2003).